{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:10:50Z","timestamp":1778821850959,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00063-020-00674-3","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T17:03:20Z","timestamp":1584032600000},"page":"175-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19","Recommendations for critically ill patients with COVID-19"],"prefix":"10.1007","volume":"115","author":[{"given":"Stefan","family":"Kluge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Weber-Carstens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Marx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Karagiannidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"674_CR1","doi-asserted-by":"publisher","unstructured":"Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS (2020) Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-020-05979-7","DOI":"10.1007\/s00134-020-05979-7"},{"key":"674_CR2","doi-asserted-by":"publisher","unstructured":"Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a\u00a0report of 72314 cases from the Chinese center for disease control and prevention. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.2648","DOI":"10.1001\/jama.2020.2648"},{"key":"674_CR3","doi-asserted-by":"publisher","unstructured":"Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X et al (2020) CT imaging features of 2019 novel coronavirus (2019-ncoV). Radiology. https:\/\/doi.org\/10.1148\/radiol.2020200230","DOI":"10.1148\/radiol.2020200230"},{"key":"674_CR4","doi-asserted-by":"publisher","unstructured":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV\u20112 pneumonia in Wuhan, China: a\u00a0single-centered, retrospective, observational study. Lancet Respir Med. https:\/\/doi.org\/10.1016\/S2213-2600(20)30079-5","DOI":"10.1016\/S2213-2600(20)30079-5"},{"key":"674_CR5","doi-asserted-by":"publisher","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et\u00a0al (2020) Clinical characteristics of coronavirus disease 2019 in China. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2002032","DOI":"10.1056\/NEJMoa2002032"},{"key":"674_CR6","doi-asserted-by":"publisher","unstructured":"Wu J, Wu X, Zeng W, Guo D, Fang Z, Chen L et\u00a0al (2020) Chest CT findings in patients with corona virus disease 2019 and its relationship with clinical features. Invest Radiol. https:\/\/doi.org\/10.1097\/RLI.0000000000000670","DOI":"10.1097\/RLI.0000000000000670"},{"key":"674_CR7","doi-asserted-by":"publisher","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et\u00a0al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","DOI":"10.1016\/S0140-6736(20)30183-5"},{"issue":"2","key":"674_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00134-020-05954-2","volume":"46","author":"X Liao","year":"2020","unstructured":"Liao\u00a0X, Wang\u00a0B, Kang\u00a0Y (2020) Novel coronavirus infection during the 2019\u20132020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. Intensive Care Med 46(2):357\u2013360","journal-title":"Intensive Care Med"},{"key":"674_CR9","unstructured":"RKI (2020) Empfehlungen des Robert Koch-Institutes zu Hygienema\u00dfnahmen im Rahmen der Behandlung von Patienten mit einer Infektion durch SARS-CoV\u20112. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Hygiene.html. Zugegriffen: 9. M\u00e4rz 2020"},{"key":"674_CR10","doi-asserted-by":"publisher","unstructured":"Arabi YM, Murthy S, Webb S (2020) COVID-19: a\u00a0novel coronavirus and a\u00a0novel challenge for critical care. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-020-05955-1","DOI":"10.1007\/s00134-020-05955-1"},{"key":"674_CR11","unstructured":"University of Liverpool (2020) Covid-19 drug interactions. http:\/\/www.covid19-druginteractions.org\/. Zugegriffen: 9. M\u00e4rz 2020"},{"key":"674_CR12","doi-asserted-by":"publisher","unstructured":"Bouadma L, Lescure FX, Lucet JC, Yazdanpanah Y, Timsit JF (2020) Severe SARS-CoV\u20112 infections: practical considerations and management strategy for intensivists. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-020-05967-x","DOI":"10.1007\/s00134-020-05967-x"},{"key":"674_CR13","unstructured":"AWMF (2020) S3-Leitlinie Sepsis \u2013 Pr\u00e4vention, Diagnose, Therapie und Nachsorge. https:\/\/www.awmf.org. Zugegriffen: 31. Dez. 2018"},{"key":"674_CR14","unstructured":"WHO (2020) Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected Interim guidance. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/clinical-management-of-novel-cov.pdf. Zugegriffen: 9. M\u00e4rz 2020"},{"key":"674_CR15","doi-asserted-by":"publisher","unstructured":"Hui DS, Chow BK, Lo T, Tsang OTY, Ko FW, Ng SS et al (2019) Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir\u00a0J. https:\/\/doi.org\/10.1183\/13993003.02339-2018","DOI":"10.1183\/13993003.02339-2018"},{"key":"674_CR16","doi-asserted-by":"publisher","unstructured":"Cheung JC, Ho LT, Cheng JV, Cham EYK, Lam KN (2020) Staff safety during emergency airway management for COVID-19 in Hong Kong. Lancet Respir Med. https:\/\/doi.org\/10.1016\/S2213-2600(20)30084-9","DOI":"10.1016\/S2213-2600(20)30084-9"},{"key":"674_CR17","unstructured":"AWMF (2017) S3-Leitlinie Invasive Beatmung und Einsatz extrakorporaler Verfahren bei akuter respiratorischer Insuffizienz. https:\/\/www.awmf.org. Zugegriffen: 4. Dez. 2017"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-020-00674-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-020-00674-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-020-00674-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T01:07:19Z","timestamp":1615511239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-020-00674-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["674"],"URL":"https:\/\/doi.org\/10.1007\/s00063-020-00674-3","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"12 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Kluge erhielt Forschungsunterst\u00fctzung der Firmen Ambu, E.T.View Ltd, Fisher & Paykel, Pfizer und Xenios. Er erhielt Vortragshonorare der Firmen ArjoHuntleigh, Astellas, Astra, Basilea, Bard, Baxter, Biotest, CSL Behring, Cytosorbents, Fresenius, Gilead, MSD, Orion, Pfizer, Philips, Sedana, Sorin, Xenios, Zoll. Er erhielt Beraterhonorare von den Firmen AMOMED, Astellas, Baxter, Bayer, Fresenius, Gilead, MSD, Pfizer und Xenios. U.\u00a0Janssens gibt an, dass kein Interessenskonflikt besteht. T.\u00a0Welte erhielt Vortragshonorare und Reiskostenunterst\u00fctzung der Firma Gilead. S.\u00a0Weber-Carstens arbeitet in einem wissenschaftlichen Kooperationsprojekt mit der Firma Dr\u00e4ger zusammen. G.\u00a0Marx erhielt Beraterhonorare und Forschungsunterst\u00fctzung durch die Firmen Biotest, B.\u00a0Braun und Adrenomed. C.\u00a0Karagiannidis erhielt Beraterhonorare der Firmen Bayer und Xenios.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}